About
Basic Data Updated:
6 days agoMarksans Pharma Limited, previously known as TASC Pharmaceuticals Limited, is a company that is involved in the production and promotion of generic pharmaceutical formulations on a global scale. The company's range of products includes various therapeutic segments such as analgesics, decongestants, gastrointestinal, cardiovascular, anti-diabetics, central nervous system, oncology, anti-allergic drugs, and others. Additionally, MPL also manufactures and distributes over-the-counter pharmaceutical products, including cough and cold remedies, galenicals, vitamins, palliative and healthcare items, oils, antiseptics, and disinfectants. Furthermore, the company offers contract research and manufacturing services to various global pharmaceutical companies. MPL's soft gel manufacturing facility, ... Read More
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Marksans Pharma Limited
Antidepressant & Anti Anxiety Medicines
Eye Care Medicines
Diabetes Medicine
Muscle Relaxant
Financials of Marksans Pharma Limited
Marksans Pharma Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.16% increase. The company also saw a slight decrease in profitability, with a 1.08% decrease in profit. The company's net worth Soared by an impressive increase of 41.63%.
Enhance accessibility to Marksans Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Marksans Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Marksans Pharma Limited
Unlock and access historical data on people associated with Marksans Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
MS
Mark Saldanha
Managing DirectorAppointment Date: 06-Oct-2015
Status: Current
JS
Jitendra Sharma CFOAppointment Date: 12-Aug-2014
Status: Current
HP
Harshavardhan Panigrahi Company SecretaryAppointment Date: 16-Feb-2009
Status: Current
Board Members(7)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 07 Feb 2006 | ₹226.00 Cr | Open |
State Bank Of India Creation Date: 07 Sep 2017 | ₹66.80 Cr | Satisfied |
State Bank Of India Creation Date: 23 Jun 2015 | ₹44.41 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marksans Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marksans Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Innovation Imaging Technologies Private Limited
Active
8 years 1 month Sunny Sharma is a mutual person
Recent activity within the organization
Annual General Meeting
Marksans Pharma Limited last Annual general meeting of members was held on 28 Aug 2023 as per latest MCA records.
28 Aug 2023Balance Sheet
Marksans Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.
31 Mar 2023Charges
A charge registered on 07 Sep 2017 via Charge ID 100125187 with State Bank Of India was fully satisfied on 29 Oct 2021.
29 Oct 2021Director Appointment
Sunny Sharma was appointed as a Director was appointed as a Director on 11 Aug 2021 & has been associated with this company since 2 years 8 months .
11 Aug 2021Director Appointment
Abhinna Mohanty Sundar was appointed as a Director was appointed as a Director on 11 Jul 2019 & has been associated with this company since 4 years 9 months .
11 Jul 2019
Recent News, Updates & Announcement
Hold Marksans Pharma target of Rs 45 Centrum .Moneycontrol 27 Nov 2017
- Marksans Pharma gets EIR from USFDA for its Goa facility.
New Delhi Drug firm Marksans Pharma said it has received Establishment Inspection Report EIR from the US health regulator for its Goa facilityThe company has received EIR from the United .
Business Medical Dialogues 10 Oct 2017
- USFDA issues 4 observations to Marksans Pharmas Verna plant.
Moneycontrol 10 Apr 2017
- MHRA completes Marksans Pharma Goa plant inspection.
Business Line 20 Feb 2017
- Marksans Pharma up 20 after inspection windup at Goa plant.
Diligent Media Corporation 20 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Marksans Pharma Limited?
